{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:12:42Z","timestamp":1781835162571,"version":"3.54.5"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,6,20]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>To investigate if there are improvements in trabeculectomy outcomes supporting filtration bleb formation caused by Rho-associated protein kinase (ROCK) inhibitors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective, multicentre, randomised, open-label clinical study examined open-angle glaucoma patients who underwent trabeculectomy or trabeculectomy combined with cataract surgery followed by 3-month postoperative ripasudil treatments. After randomly allocating patients to ripasudil\u2014ROCK inhibitor (ripasudil) or without ripasudil (non-ripasudil) groups. Mean intraocular pressure (IOP) changes, success rate, and number of eyedrops were compared for both groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 17 and 15 subjects dropped out in the ripasudil group and non-ripasudil group, respectively. At baseline, the mean IOP was 16.8\u00b15.0\u2009mm Hg in the ripasudil group (38 patients) and 16.2\u00b14.4 in the non-ripasudil group (52 patients). The IOP decreased to 11.4\u00b13.2\u2009mm Hg, 10.9\u00b13.9\u2009mm Hg and 10.6\u00b13.5\u2009mm Hg at 12, 24 and 36 months in the ripasudil group, while it decreased to 11.2\u00b14.1\u2009mm Hg, 10.5\u00b13.1\u2009mm Hg and 10.9\u00b13.2\u2009mm Hg at 12, 24 and 36 months in the non-ripasudil group, respectively. There was a significant decrease in the number of IOP-lowering medications after trabeculectomy in the ripasudil group versus the non-ripasudil group at 24 (p=0.010) and 36 months (p=0.016). There was no statistically significant difference between the groups for the 3-year cumulative probability of success.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Although ripasudil application did not increase the primary trabeculectomy success rate, it did reduce IOP-lowering medications after trabeculectomy with mitomycin C.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2023-001449","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:30:21Z","timestamp":1719966621000},"page":"e001449","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of ripasudil after trabeculectomy with mitomycin C: a multicentre, randomised, prospective clinical study"],"prefix":"10.1136","volume":"9","author":[{"given":"Aisyah","family":"Muhlisah","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2977-124X","authenticated-orcid":false,"given":"Kazuyuki","family":"Hirooka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariyanie","family":"Nurtania","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Onoe","sequence":"additional","affiliation":[{"name":"Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-2219","authenticated-orcid":false,"given":"Hideaki","family":"Okumichi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kagawa University Faculty of Medicine Graduate School of Medicine, Kita-gun, Kagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shirai Eye Hospital, Mitoyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Tanito","sequence":"additional","affiliation":[{"name":"Shimane University Faculty of Medicine Graduate School of Medicine Department of Ophthalmology, Izumo, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yotaro","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Matsue Red Cross Hospital, Matsue, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-1862","authenticated-orcid":false,"given":"Shunsuke","family":"Nakakura","sequence":"additional","affiliation":[{"name":"Ophthalmology, Saneiekai Tsukazaki Hospital, Himeji, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-1864","authenticated-orcid":false,"given":"Yoshiaki","family":"Kiuchi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hiroshima University Faculty of Medicine Graduate School of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"2025090109095098000_9.1.e001449.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3192"},{"key":"2025090109095098000_9.1.e001449.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.140939"},{"key":"2025090109095098000_9.1.e001449.3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/ICU.0b013e32834ff401","article-title":"Current variations of glaucoma filtration surgery","volume":"23","author":"Salim","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"2025090109095098000_9.1.e001449.4","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(87)90091-9"},{"key":"2025090109095098000_9.1.e001449.5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0118"},{"key":"2025090109095098000_9.1.e001449.6","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.7.6.6","article-title":"Rho-kinase inhibition reduces Myofibroblast differentiation and proliferation of Scleral fibroblasts induced by transforming growth factor \u0392 and experimental glaucoma","volume":"7","author":"Pitha","year":"2018","journal-title":"Transl Vis Sci Technol"},{"key":"2025090109095098000_9.1.e001449.7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbf.3382","article-title":"An in vitro study of Scarring formation mediated by human tenon fibroblasts: effect of Y-27632, a Rho kinase inhibitor","volume":"37","author":"Ibrahim","year":"2019","journal-title":"Cell Biochem Funct"},{"key":"2025090109095098000_9.1.e001449.8","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2013.874444"},{"key":"2025090109095098000_9.1.e001449.9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0878"},{"key":"2025090109095098000_9.1.e001449.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-022-02680-9","article-title":"Effect of the Rho-kinase inhibitor Ripasudil in Needling with mitomycin C for the failure of filtering Bleb after Trabeculectomy: a cross-sectional study","volume":"22","author":"Mizuno","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"2025090109095098000_9.1.e001449.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(00)00135-1"},{"key":"2025090109095098000_9.1.e001449.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.23677"},{"key":"2025090109095098000_9.1.e001449.13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exer.2016.07.001","article-title":"The effects of Ripasudil (K-115), a Rho kinase inhibitor, on activation of human Conjunctival fibroblasts","volume":"149","author":"Futakuchi","year":"2016","journal-title":"Exp Eye Res"},{"key":"2025090109095098000_9.1.e001449.14","first-page":"23","article-title":"Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye","volume":"34","author":"Pasquale","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025090109095098000_9.1.e001449.15","first-page":"67","article-title":"Effects of Ripasudil, a Rho-associated protein kinase inhibitor, on Conjunctival Scarring in a canine filtration surgery model","volume":"19","author":"Kojima","year":"2015","journal-title":"Curr Topics Pharmacol"},{"key":"2025090109095098000_9.1.e001449.16","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200306000-00015"},{"key":"2025090109095098000_9.1.e001449.17","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1990.6.175"},{"key":"2025090109095098000_9.1.e001449.18","doi-asserted-by":"crossref","DOI":"10.2174\/18743641-v16-e2206201","article-title":"Early postoperative effects of Ripasudil hydrochloride after Trabeculectomy in secondary glaucoma: a randomized controlled trial","volume":"16","author":"Mimura","year":"2022","journal-title":"Toophtj"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2023-001449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:09:57Z","timestamp":1756742997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2023-001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7,2]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjophth-2023-001449"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2023-001449","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}